Data as of Q4 2025 (Dec 31, 2025)

UTI

(UTI)

Financial Statements · SEC EDGAR XBRL

Revenue
$835.6M
+14.0%
Net Income
$63.0M
+50.0%
EPS
$1.13
+50.7%
Op. Income
$83.5M
+41.7%
Source: SEC EDGAR XBRL
Breakdown
Revenues
Revenues
Total Revenues
Operating Expenses & Income
Operating Income
Non-Operating Income/Expense
Net Income
EPS (Basic)
EPS (Diluted)
FY 2025
FY 2024
FY 2023
FY 2022
FY 2021
$835.6M
$732.7M
$607.4M
$418.8M
$335.1M
$835.6M
$732.7M
$607.4M
$418.8M
$335.1M
$83.5M
$58.9M
-
$22.4M
$14.9M
$63.0M
$42.0M
-
$25.8M
$14.6M
$1.16
$0.77
-
$0.39
-
$1.13
$0.75
-
$0.38
-